XBiotech Halts Rheumatology Program After Phase II Rheumatoid Arthritis Study Fails To Meet Primary Endpoint Amid Data Irregularities; Future Studies On Hold Pending Further Analysis Of Findings
XBiotech Halts Rheumatology Program After Phase II Rheumatoid Arthritis Study Fails To Meet Primary Endpoint Amid Data Irregularities; Future Studies On Hold Pending Further Analysis Of Findings
XBiotech暫停風溼病項目,此前II期類風溼關節炎研究未能滿足主要終點,數據出現不規律;未來研究持有,待進一步分析結果。
XBiotech Halts Rheumatology Program After Phase II Rheumatoid Arthritis Study Fails To Meet Primary Endpoint Amid Data Irregularities; Future Studies On Hold Pending Further Analysis Of Findings
XBiotech暫停風溼病項目,此前II期類風溼關節炎研究未能滿足主要終點,數據出現不規律;未來研究持有,待進一步分析結果。